The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...
In Destiny’s Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance ...
Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more individualized care, including changes in medication, referrals to clinical ...
That's what a team of scientists in the Czech Republic did this year to celebrate Gregor Mendel, a scientist and friar whose experiments in the mid-1800s laid the groundwork for modern genetics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback